AssetMark’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.05K Hold
47
– – ﹤0.01% 2824
2026
Q2
$4.49K Hold
47
– – ﹤0.01% 2726
2026
Q1
$4.52K Buy
47
+9
+24% +$900 ﹤0.01% 2596
2025
Q4
$3.7K Hold
38
– – ﹤0.01% 2568
2025
Q3
$2.7K Hold
38
– – ﹤0.01% 2551
2025
Q2
$2.27K Buy
38
+11
+41% +$603 ﹤0.01% 2390
2025
Q1
$1.42K Buy
+27
New +$1.52K ﹤0.01% 2241

Other funds holding IRMD

AssetMark's IRMD Position: Q3 2026 in Review

AssetMark held its iRadimed (IRMD) position steady in Q3 2026 at 47 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

AssetMark first reported a position in IRMD in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.52K in Q1 2026. 157 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • AssetMark held 47 shares of iRadimed worth $4.05K as of Q3 2026.
  • AssetMark left its iRadimed share count unchanged in Q3 2026.
  • iRadimed made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2824 holding.
  • AssetMark first reported a position in iRadimed in Q1 2025 and has held it in 7 quarters since.
  • AssetMark's iRadimed position peaked at $4.52K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.